Business Wire

Cellares’ Cell Shuttle™ Receives FDA Advanced Manufacturing Technology (AMT) Designation for Automated Cell Therapy Manufacturing

The AMT designation gives Cellares’ clients using the Cell Shuttle priority review with the FDA leading to accelerated regulatory filings SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the ...
FiercePharma

All aboard the Cell Shuttle: Cellares' cell therapy factory-in-a-box project attracts a 3rd partner in Poseida

With a third collaborator in tow, Cellares has all the expertise it needs to turn its focus from scouting out industry partners to tweaking and improving its forthcoming cell therapy factory in a box.
Nasdaq

Cellares and Lyell to Evaluate Automated Manufacturing of Lyell's CAR T-Cell Therapy on Cellares' Cell Shuttle Platform

SOUTH SAN FRANCISCO, Calif., Sept. 11, 2023 /PRNewswire/ -- Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy ...
Seeking Alpha

Cellares Announces Bristol Myers Squibb has Joined Technology Adoption Partnership Program to Evaluate Automated Manufacturing of CAR-T Cell Therapy on the Cell Shuttle Platform

Cellares to provide proof-of-concept manufacturing for a key BMS CAR-T cell therapy Cellares' proprietary Cell Shuttle is a cost-efficient, reliable, fully automated, and highly scalable manufacturing ...